8. Lu S, Sun YH, Shi R, Clark C, Li L, et al. (2005) Novel and mechanical stress- responsive MicroRNAs in Populus trichocarpa that are absent from Arabidopsis. Plant Cell 17: 2186–2203. 9. Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acid Res 33: 1290–1297. 10. Xu P, Guo M, Hay BA (2004) MicroRNAs and the regulation of cell death. Trends Genet 20: 617–624. 11. Karp X, Ambros V (2005) Developmental biology. Encountering microRNAs in cell fate signaling. Science 310: 1288–1289. 12. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83–86. 13. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226–230. 14. Houbaviy HB, Murray MF, Sharp PA (2003) Embryonic stem cell-specific MicroRNAs. Dev Cell 5: 351–358. 15. Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, et al. (2004) Human embryonic stem cells express a unique set of microRNAs. Dev Biol 270: 488–498. 16. Zhang L, Coukos G (2006) MicroRNAs: a new insight into cancer genome. Cell Cycle 5: 2216–2219. 17. Slack FJ, Weidhaas JB (2006) MicroRNAs as a potential magic bullet in cancer. Future oncol 2: 73–82. 18. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, et al. (2005) A microRNA polycistron as a potential human oncogene. Nature 435: 828–833. 19. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257–2261. 20. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239–257. 21. Radovic´ N, Cucic´ S, Altarac S (2008) Molecular aspects of apoptosis. Acta Med Croatica 62: 249–256. 22. Li H, Zhu H, Xu CJ, Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491–501. 23. Cregan PS, Dawson VL, Slack RS (2004) Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23: 2785–2796. 24. Kim PK, Dutra AS, Chandrasekharappa SC, Puck JM (1996) Genomic structure and mapping of human FADD, an intracellular mediator of lymphocyte apoptosis. J Immunol 157: 5461–5466. 25. Newton K, Harris AW, Strasser A (2000) FADD/MORT1 regulates the pre- TCR checkpoint and can function as a tumour suppressor. EMBO J 19: 931–941. 26. Tourneur L, Mistou S, Michiels FM, Devauchelle V, Renia L, et al. (2003) Loss of FADD protein expression results in a biased Fas-signaling pathway and correlates with the development of tumoral status in thyroid follicular cells. Oncogene 22: 2795–2804. 27. Tourneur L, Delluc S, Levy V, Valensi F, Radford-Weiss I, et al. (2004) Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome. Cancer Res 64: 8101–8108. 28. Pfaffl MW (2001) A new mathematical model for relative quantification in real- time RT-PCR. Nucleic Acid Res 29: 2002–2007. 29. Su YT, Chang HL, Shyue SK, Hsu SL (2005) Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem Pharmacol 70: 229–241. 30. Goel A, Prasad AK, Parmar VS, Ghosh B, Saini N (2007) 7,8-Dihydroxy-4- methylcoumarin induces apoptosis of human lung adenocarcinoma cells by ROS-independent mitochondrial pathway through partial inhibition of ERK/ MAPK signaling. FEBS Lett 581: 2447–2454. 31. Khanna N, Jayaram HN, Singh N (2004) Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells. Life Sci 75: 179–190. miRNA Cluster Induce Apoptosis 32. Dvorak Z, Vrzal R, Maurel P, Ulrichova J (2006) Differential effects of selected natural compounds with anti- inflammatory activity on the glucocorticoid receptor and NF-kB in Hela cells. Chemico-Biol. Interactions 159: 117–128. 33. Parre n˜o M, Casanova I, Ce´spedes MV, Vaque´ JP, Pavo´n MA, et al. (2008) Bobel-24 and derivatives induce caspase-independent death in pancreatic cancer regardless of apoptotic resistance. Cancer Res 68: 6313–6323. 34. Cho WC (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 25 6: 60. 35. Shi XB, Tepper CG, deVere White RW (2008) Cancerous miRNAs and their regulation. Cell Cycle 7: 1529–1538. 36. O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc- regulated microRNAs modulate E2F1 expression. Nature 435: 839–843. 37. Huang S, He X, Ding J, Liang L, Zhao Y, et al. (2008) Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta- induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer 123: 972–978. 38. Tait SW, Green DR (2008) Caspase-independent cell death: leaving the set without the final cut. Oncogene 27: 6452–6461. 39. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515–524. 40. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363. 41. Rehmsmeier M, Steffen P, Ho¨chsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10: 1507–1517. 42. Lewis BP, Burge CB, Bartel DP (2005) Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets. Cell 120: 15–20. 43. Yeh WC, Hakem R, Woo M, Mak TW (1999) Gene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling. Immunol Rev 169: 283–302. 44. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281: 1305–1308. 45. Muzio M, Chinnaiyan AM, Kischkel FC, O’Rourke K, hevchenko A, et al. (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817–827. 46. Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803–815. 47. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, et al. (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death- inducing signaling complex (DISC) with the receptor. EMBO J 14: 5579–5588. 48. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, et al. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16: 2794–2804. 49. Inman GJ, Allday MJ (2000) Apoptosis induced by TGF-{beta}1 in Burkitt’s lymphoma cells is caspase 8 dependent but is death receptor independent. J Immunol 165: 2500–2510. 50. Wesselborg S, Engels IH, Rossmann E, Los M, Schulze-Osthoff K (1999) Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood 93: 3053–3063. 51. Ohara M, Hayashi T, Kusunoki Y, Nakachi K, Fujiwara T, et al. (2008) Cytolethal distending toxin induces caspase-dependent and -independent cell death in MOLT-4 cells. Infect Immun 76: 4783–4791. 52. Thayyullathil F, Chathoth S, Hago A, Patel M, Galadari S (2008) Rapid reactive oxygen species (ROS) generation induced by curcumin leads to caspase- dependent and-independent apoptosis in L929 cells. Free Radic Biol Med 45: 1403–1412. 53. Chen G, Goeddel DV (2002) TNF-R1 signaling: a beautiful pathway. Science 296: 1634–35. PLoS ONE | www.plosone.org 11 June 2009 | Volume 4 | Issue 6 | e5848